Biomarker-Guided Tailored Therapy in Major Depression.

Adv Exp Med Biol

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Published: September 2024

AI Article Synopsis

Article Abstract

This chapter provides a comprehensive examination of a broad range of biomarkers used for the diagnosis and prediction of treatment outcomes in major depressive disorder (MDD). Genetic, epigenetic, serum, cerebrospinal fluid (CSF), and neuroimaging biomarkers are analyzed in depth, as well as the integration of new technologies such as digital phenotyping and machine learning. The intricate interplay between biological and psychological elements is emphasized as essential for tailoring MDD management strategies. In addition, the evolving link between psychotherapy and biomarkers is explored to uncover potential associations that shed light on treatment response. This analysis underscores the importance of individualized approaches in the treatment of MDD that integrate advanced biological insights into clinical practice to improve patient outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-97-4402-2_19DOI Listing

Publication Analysis

Top Keywords

biomarker-guided tailored
4
tailored therapy
4
therapy major
4
major depression
4
depression chapter
4
chapter comprehensive
4
comprehensive examination
4
examination broad
4
broad range
4
range biomarkers
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!